A rapid whole-genome sequencing service for infants with rare diseases in the United Arab Emirates.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Citywide implementation of a rapid whole-genome sequencing program for critically ill pediatric patients.Nature medicine · 2026
   Article
2. Scaling rapid whole-genome sequencing for critical pediatric care in the Middle East.Nature medicine · 2026
   Article
3. Holistic precision wellness: Paving the way for next-generation precision medicine (ngPM) with AI, biomedical informatics, and clinical medicine.FASEB bioAdvances · 2025
   Article
4. Genomics of rare diseases in the Greater Middle East.Nature genetics · 2025
   Review
5. The WHO genomics program of work for equitable implementation of human genomics for global health.Nature medicine · 2024
   Article

Corrections and comments

• Comment on
  Integrated multi-omics for rapid rare disease diagnosis on a national scale.2023

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as